in vitro diagnostics Market to grow with 2.8% CAGR during 2021 to 2031

The in vitro diagnostics market was valued at USD 99.2 billion in 2021 and it is anticipated to grow further till USD 131.2 billion by 2031, at a CAGR of 2.8% during the forecast period.

Global in vitro diagnostics report from Global Insight Services is the single authoritative source of intelligence on in vitro diagnosticsmarket. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about in vitro diagnostics market here: https://www.globalinsightservices.com/reports/in-vitro-diagnostics-ivd-market/

To Remain 'Ahead' Of Your Competitors, Request for A Sample -

Major Players in the Global In Vitro Diagnostics Market
The key players in the global in vitro diagnostics market are Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Abbott (US), Thermo Fisher Scientific (US), Johnson & Johnson (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Sysmex Corporation (Japan), bioMérieux (France), DiaSorin (Italy), Ortho Clinical Diagnostics (US), and QIAGEN N.V. (Netherlands) among others.
Global In Vitro Diagnostics Market Segmental Overview
The report analyses the global in vitro diagnostics market based on the product & service, technology, application, end user, and region.

Global In Vitro Diagnostics Market by Product & Service
Based on the products & service, it is segmented into reagents & kits, instruments, services, and data management software. The reagents & kits segment is anticipated to dominate the market during the forecast period. This market's expansion is anticipated to be fueled by the availability of a broad variety of reagents and the demand for accurate, expedient, and quick diagnosis of genetic disorders and chronic diseases in their early stages.

Global In Vitro Diagnostics Market by Technology
Based on the technology, it is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation and hemostasis, urinalysis, and others. The immunoassay/immunochemistry segment is anticipated to dominate the market during the forecast period. This market sector is expanding as a consequence of the increasing demand for these technologies in clinical diagnostics over traditional approaches and the ability of immunoassay/immunochemistry technologies to provide faster findings with high sensitivity and accuracy.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS20055

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.